二叶式与三叶式主动脉瓣患者常规主动脉瓣置换术后永久起搏器植入率的倾向匹配分析:为经导管主动脉瓣置换术提供基准
该单中心回顾性研究分析了2000至2019年间4154例孤立性主动脉瓣置换术患者,其中二叶式主动脉瓣1108例(27%)。总体永久起搏器植入率二叶式组显著高于三叶式组(5.4% vs 3.8%,P=0.03),但倾向匹配后无差异(5.1% vs 4.4%,P=0.5)。术后永久起搏器植入率远低于经导管主动脉瓣置换术报道的发生率。
要点
- 二叶式主动脉瓣患者行外科主动脉瓣置换术后永久起搏器植入率总体高于三叶式(5.4% vs 3.8%)。
- 倾向匹配后两组起搏器植入率相似(5.1% vs 4.4%),二叶式并非独立危险因素。
- 外科主动脉瓣置换术后起搏器植入率显著低于经导管主动脉瓣置换术报道的9-15%。
核心结论
- 外科主动脉瓣置换术后二叶式主动脉瓣患者永久起搏器植入率总体显著高于三叶式,但倾向匹配后无差异。
- 二叶式患者术后起搏器植入率明显低于经导管主动脉瓣置换术报道的发生率。
研究设计与样本
- 回顾性单中心分析,纳入2000至2019年间4154例孤立性外科主动脉瓣置换术患者,其中二叶式主动脉瓣1108例(27%)。
- 采用1:1最近邻匹配以提高人口学不均衡队列的可比性。
主要发现
- 二叶式患者手术时平均年龄比三叶式患者小10岁(59.7±12 vs 69.3±9,P<0.001)且合并症更少。
- 总体永久起搏器植入率二叶式组显著更高(5.4% vs 3.8%,P=0.03)。
- 二叶式组起搏器植入全部(100%)因持续性术后高度房室传导阻滞,三叶式组主要(96%)因该原因。
- 匹配后起搏器植入率相似(5.1% vs 4.4%,P=0.5)。
- 匹配队列院内死亡率两组均为1%;二叶式组长期生存更优(5年94% vs 90%,9年89% vs 82%,P=0.013)。
关键数值与推荐
- 总体永久起搏器植入率:二叶式5.4% vs 三叶式3.8%(P=0.03)。
- 匹配后永久起搏器植入率:二叶式5.1% vs 三叶式4.4%(P=0.5)。
- 匹配队列院内死亡率:两组均为1%。
- 长期生存:二叶式5年94% vs 三叶式90%,9年89% vs 82%(P=0.013)。
临床怎么用
- 为经导管主动脉瓣置换术的起搏器植入风险提供外科基准,尤其适用于二叶式主动脉瓣患者。
- 二叶式患者行外科主动脉瓣置换术后起搏器植入风险低,不应因担心起搏器植入而推迟手术。
局限性
- 回顾性单中心设计,可能存在选择偏倚和未测量混杂。
- 原文未报告匹配后样本量、置信区间等详细统计信息。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Elective treatment of aortic valve disease by transcatheter aortic valve replacement (TAVR) is becoming increasingly popular, even in patients with low risk and intermediate risk. Even patients with a bicuspid aortic valve (BAV) are increasingly considered eligible for TAVR. Permanent pacemaker implantation (PMI) is a known-frequently understated-complication of TAVR affecting 9-15% of TAVR patients with a potentially significant impact on longevity and quality of life. BAV patients are affected by the highest PMI rates, although they are frequently younger compared to their tricuspid peers. The aim of the study is to report benchmark data-from a high-volume centre (with a competitive TAVR programme) on PMI after isolated surgical aortic valve replacement (SAVR) in patients with BAV and tricuspid aortic valve (TAV). METHODS: We performed a retrospective single-centre analysis on 4154 patients receiving isolated SAVRs (w/o concomitant procedures), between 2000 and 2019, of whom 1108 had BAV (27%). PMI rate and early- and long-term outcomes were analysed. For better comparability of these demographically unequal cohorts, 1:1 nearest neighbour matching was performed. RESULTS: At the time of SAVR, BAV patients were on average 10 years younger than their TAV peers (59.7 ± 12 vs 69.3 ± 9; P < 0.001) and had less comorbidities; all relevant characteristics were equally balanced after statistical matching. Overall PMI rate was significantly higher in BAV patients (5.4% vs 3.8%; P = 0.03). BAV required PMI exclusively (100%) and TAV required predominately (96%) for persistent postoperative high-degree atrioventricular block. After matching, the PMI rate was similar (5.1% vs 4.4%, P = 0.5). In-hospital mortality in the matched cohort was 1% in both groups. Long-term survival was more favourable in BAV patients (94% vs 90% in TAV at 5 years; 89% vs 82% in TAV at 9 years; P = 0.013). CONCLUSIONS: With SAVR, the overall incidence of PMI among BAV patients seems significantly higher; however, after propensity matching, no difference in PMI rates between BAV and TAV is evident. The PMI rate was remarkably lower among BAV patients after SAVR compared to the reported incidence after TAVR.
引用
- Haunschild J, Misfeld M, Schroeter T, et al. Prevalence of permanent pacemaker implantation after conventional aortic valve replacement-a propensity-matched analysis in patients with a bicuspid or tricuspid aortic valve: a benchmark for transcatheter aortic valve replacement. Eur J Cardiothorac Surg. 2020. PMID: 32211779. doi:10.1093/ejcts/ezaa053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。